The impact of laronidase treatment in otolaryngological manifestations of patients with mucopolysaccharidosis()

INTRODUCTION: Mucopolysaccharidosis (MPS) is a lysosomal storage disease caused by deficiency of α-l-iduronidase. The otolaryngological findings include hearing loss, otorrhea, recurrent otitis, hypertrophy of tonsils and adenoid, recurrent rhinosinusitis, speech disorders, snoring, oral breathing a...

Descripción completa

Detalles Bibliográficos
Autores principales: Dualibi, Ana Paula Fiuza Funicello, Martins, Ana Maria, Moreira, Gustavo Antônio, de Azevedo, Marisa Frasson, Fujita, Reginaldo Raimundo, Pignatari, Shirley Shizue Nagata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444600/
https://www.ncbi.nlm.nih.gov/pubmed/26750310
http://dx.doi.org/10.1016/j.bjorl.2015.09.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444600/
https://www.ncbi.nlm.nih.gov/pubmed/26750310
http://dx.doi.org/10.1016/j.bjorl.2015.09.006

Ejemplares similares